Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

NCT07085559 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma (MM)
Plasma Cell Leukemia (PCL)
AL Amyloidosis (AL)

Interventions

DRUG: Metabolically Armed BCMA CAR-T cells.

Sponsor

Anhui Provincial Hospital

Collaborators

[object Object]